Showing results (171-180 of 226) with videos related to
Sort By:
Pageof 23
Archives of Neurology|August 16, 2006
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosisDouglas E Gladstone, Kenneth W Zamkoff, Lauren Krupp, et al.Journal of the Neurological Sciences|November 18, 2023
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) studyDejan Jakimovski, Katelyn S Kavak, Karen Zakalik, et al.Neurology|November 27, 2002
Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE TrialH Panitch, D S Goodin, G Francis, et al.Neurology|November 1, 1995
Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme diseaseP K Coyle, S E Schutzer, Z Deng, et al.BMC Neurology|March 15, 2014
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomesPatricia K Coyle, Bruce A Cohen, Thomas Leist, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 11, 2019
Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experienceSandra Vukusic, Patricia K Coyle, Stephanie Jurgensen, et al.Multiple Sclerosis and Related Disorders|August 9, 2023
Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemicPatricia K Coyle, Magdaliz Gorritz, Rolin L Wade, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
Multiple sclerosis gender issues: clinical practices of women neurologistsP K Coyle, S Christie, P Fodor, et al.Preventive Medicine|February 5, 2011
The association between school-based physical activity, including physical education, and academic performance: a systematic review of the literatureCatherine N Rasberry, Sarah M Lee, Leah Robin, et al.Lancet (London, England)|August 2, 1980
Cerebrospinal-fluid lymphocyte populations and immune complexes in active multiple sclerosisP K Coyle, B R Brooks, R L Hirsch, et al.Pageof 23